BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 6335615)

  • 1. [Prediction of the effectiveness of levamisole immunotherapy by the sensitivity of blood lymphocytes to the drug].
    Giulling EV; Kravchuk GP; Kazirchuk VE; Maksiuk LV; Zabolotnyĭ DI
    Vrach Delo; 1984 Nov; (11):38-42. PubMed ID: 6335615
    [No Abstract]   [Full Text] [Related]  

  • 2. [Method of determining the sensitivity of lymphocytes to immunomodulators of the phenylimidazothiazole group].
    Kazmirchuk VE; Bychkova NG; Andrushchuk AA; Giulling EV; Kravchuk GP
    Lab Delo; 1985; (3):169-71. PubMed ID: 2581051
    [No Abstract]   [Full Text] [Related]  

  • 3. [Levamisole in the combined treatment of patients with ischemic heart disease].
    Gorb GD; Makovskaia TE; Tsybul'nik ZI; Grushko IV; Eremeev VS
    Vrach Delo; 1988 Aug; (8):38-40. PubMed ID: 3264642
    [No Abstract]   [Full Text] [Related]  

  • 4. [Increased sensitivity of E-rosette-forming blood lymphocytes to histamine in human T-immunodeficient states].
    Giulling EV; Kravchuk GP
    Fiziol Zh (1978); 1984; 30(6):740-3. PubMed ID: 6335103
    [No Abstract]   [Full Text] [Related]  

  • 5. Levamisole and immunotherapy: some theoretic and practical considerations and their relevance to human disease.
    Amery WK; Gough DA
    Oncology; 1981; 38(3):168-81. PubMed ID: 7010258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Prediction of the sensitivity of chronic lympholeukemia patients to levamisole].
    Martynova VA; Sevast'ianova MG; Ermakova GL
    Gematol Transfuziol; 1985 Sep; 30(9):7-10. PubMed ID: 3876965
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of taktivin and levamisole in the combined treatment of diffuse toxic goiter].
    Balabolkin MI; Arion VIa; Petunina NA
    Sov Med; 1987; (12):32-5. PubMed ID: 3502197
    [No Abstract]   [Full Text] [Related]  

  • 8. [Concepts of stimulating immunotherapy].
    Aiuti F; Montella F
    Minerva Med; 1982 Apr; 73(15):895-8. PubMed ID: 6176915
    [No Abstract]   [Full Text] [Related]  

  • 9. [Analysis of immunocompetent cell subpopulations in chronic bronchitis patients during the use of different immunomodulating preparations].
    Karaulov AV; Sil'vestrov VP; Martsinovskiĭ VIu; Bulycheva NA; Likov VF
    Ter Arkh; 1984; 56(10):14-7. PubMed ID: 6335305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [State of cellular and humoral immunity in recurrent and chronic bronchopulmonary diseases in children before and after immunostimulation with levamisole].
    Błaszczyk E; Kulczyk BA
    Wiad Lek; 1985 Apr; 38(7):495-9. PubMed ID: 3874484
    [No Abstract]   [Full Text] [Related]  

  • 11. [Possibilities of immunotherapy in chronic pancreatitis].
    Gubergrits NB; Gubergrits EA
    Sov Med; 1991; (4):52-4. PubMed ID: 1871631
    [No Abstract]   [Full Text] [Related]  

  • 12. Induction of E-rosette-promoting factor in human plasma by levamisole: an assessment in a patient with partial DiGeorge syndrome.
    Seki H; Yokoi T; Kubo M; Moriya N; Miyawaki T; Nagaoki T; Miura M; Taniguchi N
    Scand J Immunol; 1982 Feb; 15(2):141-8. PubMed ID: 6980445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Difficulties in the immunologic and clinical control of nonspecific immunotherapy of bronchial asthma].
    Bobkova LP; Kostiuk AG; Petrovskaia IA; Evseeva TA; Ezerskaia RV
    Ter Arkh; 1988; 60(8):109-14. PubMed ID: 3265810
    [No Abstract]   [Full Text] [Related]  

  • 14. [Combined immunocorrection--a prospective method for treating secondary immunodeficiency].
    Perederiĭ VG; Zemskov AM; Provotorov VM; Nikitin AV; Evstratova EF
    Vrach Delo; 1989 Jan; (1):96-8. PubMed ID: 2718463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunopharmacology of levamisole].
    Symoens J
    Z Hautkr; 1979 May; 54(9):394-402. PubMed ID: 375604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Principles of a differentiated immunocorrective therapy].
    Perederiĭ VG; Zemskov AM
    Vrach Delo; 1988 Aug; (8):71-4. PubMed ID: 3264643
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of levamisole, an immune controlling agent in various clinical conditions mainly liver diseases (author's transl)].
    Miyake M
    Fukuoka Igaku Zasshi; 1981 Jun; 72(6):368-78. PubMed ID: 6975743
    [No Abstract]   [Full Text] [Related]  

  • 18. [Use of a thymus polypeptide preparation to diagnose and correct immune deficiency states in multiple sclerosis].
    Golovkin VI; Ankhimova ES; Morozov VG; Khavinson VG
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):179-82. PubMed ID: 6201026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Levamisole as an immunostimulant.
    Pár A
    Ther Hung; 1980; 28(4):163-7. PubMed ID: 6782693
    [No Abstract]   [Full Text] [Related]  

  • 20. [Comparative effectiveness of immunomodulators in the therapy of rheumatic heart defects].
    Zemskov AM; Provotorov VM; Evstratova EF; Zemskov VM
    Antibiotiki; 1984 Jun; 29(6):460-3. PubMed ID: 6332572
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.